Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Not yet recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 128Colonic Neoplasms 54Rectal Neoplasms 49Carcinoma, Hepatocellular 29Stomach Neoplasms 23Neoplasm Metastasis 22Neoplasms 11Pancreatic Neoplasms 10Cholangiocarcinoma 9Adenocarcinoma Of Esophagus 8Esophageal Neoplasms 7Liver Neoplasms 6Gastrointestinal Neoplasms 5Biliary Tract Neoplasms 5Recurrence 4Ovarian Neoplasms 4Esophageal Squamous Cell Carcinoma 3Digestive System Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Adenocarcinoma 3Unresectable Metastatic Colorectal Cancer 2Peritoneal Neoplasms 2Neurotoxicity Syndromes 2Neoplastic Cells, Circulating 2Intestinal Neoplasms 2Gastrointestinal Diseases 2Gallbladder Neoplasms 2Colorectal Cancer Metastatic 2Cirrhosis, Familial, with Pulmonary Hypertension 2

Interventions

Fluorouracil 4lenvatinib 3Surgical Procedures, Operative 3Oxaliplatin 3Leucovorin 3Drug Therapy 3Gemcitabine 2Folfox protocol 2Floxuridine 2regorafenib 1gemcitabine-oxaliplatin regimen 1durvalumab 1donafenib 1apatinib 1Radiotherapy 1Irinotecan 1Hepatectomy 1Dexamethasone 1Cryosurgery 1Cisplatin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Cirrhosis, Familial, with Pulmonary Hypertension × Folfox protocol × Clear all
NCT07353827 2026-01-20

FOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma

Sun Yat-sen University

Phase 2 Not yet recruiting
36 enrolled
Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT06946849 2025-04-27

SED-RO-ICC

Shanghai Zhongshan Hospital

Phase 2 Not yet recruiting
76 enrolled
Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡